Search

Author/Creator Gonzalez, Jose Luis

1. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease. Issue 12 (25th October 2022)

Authors:
Ayyala, Divya; Bottyan, Thomas; Tien, Christine; Pimienta, Michael; Yoo, Jennie; Stager, Kelli; Gonzalez, Jose Luis; Stolz, Andrew; Dodge, Jennifer L.; Terrault, Norah A.; Han, Hyosun
Journal:
Hepatology communications
Issue:
Volume 6:Issue 12(2022)
Page Start:
3433
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search